2026-06-14T02:23:43Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/133262025-05-27T08:31:29Zcom_20.500.12105_2052com_20.500.12105_2051col_20.500.12105_19618

00925njm 22002777a 4500 dc Riad, Abanoub author Schünemann, Holger author Attia, Sameh author Peričić, Tina Poklepović author Žuljević, Marija Franka author Jürisson, Mikk author Kalda, Ruth author Lang, Katrin author Morankar, Sudhakar author Yesuf, Elias Ali author Mekhemar, Mohamed author Danso-Appiah, Anthony author Sofi-Mahmudi, Ahmad author Pérez-Gaxiola, Giordano author Dziedzic, Arkadiusz author Apóstolo, João author Cardoso, Daniela author Marc, Janja author Moreno-Casbas, Teresa author Wiysonge, Charles Shey author Qaseem, Amir author Gryschek, Anna author Tadić, Ivana author Hussain, Salman author Khan, Mohammed Ahmed author Klugarova, Jitka author Pokorna, Andrea author Koščík, Michal author Klugar, Miloslav author 2021 Background: Coronavirus disease (COVID-19) vaccine-related side effects have a determinant role in the public decision regarding vaccination. Therefore, this study has been designed to actively monitor the safety and effectiveness of COVID-19 vaccines globally. Methods: A multi-country, three-phase study including a cross-sectional survey to test for the short-term side effects of COVID-19 vaccines among target population groups. In the second phase, we will monitor the booster doses' side effects, while in the third phase, the long-term safety and effectiveness will be investigated. A validated, self-administered questionnaire will be used to collect data from the target population; Results: The study protocol has been registered at ClinicalTrials.gov, with the identifier NCT04834869. Conclusions: CoVaST is the first independent study aiming to monitor the side effects of COVID-19 vaccines following booster doses, and the long-term safety and effectiveness of said vaccines. Int. J. Environ. Res. Public Health 2021; 18(15), 7859 10.3390/ijerph18157859 1660-4601 International Journal of Environmental Research and Public Health 34360156 http://hdl.handle.net/20.500.12105/13326 COVID-19 Cohort studies Cross-sectional studies Drug-related side effects and adverse reactions Health personnel Mass vaccination Prevalence COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of a Multi-Center Prospective Cohort Study for Active Surveillance of COVID-19 Vaccines' Side Effects